The Development of Artificial Neural Networks to Predict Virological response to Combination HIV Therapy
暂无分享,去创建一个
Brendan Larder | Lidia Ruiz | Andrew Revell | Scott Wegner | María Jésus Pérez-Elías | Sean Emery | Jose Gatell | Carlo Torti | Maurizio Zazzi | Richard Harrigan | Julio Montaner | B. Larder | J. Montaner | L. Ruiz | J. Gatell | M. Zazzi | S. Emery | A. Monforte | F. de Wolf | A. Revell | R. Harrigan | C. Torti | Dechao Wang | S. Wegner | J. Lange | M. Pérez-Elías | C. Lane | Dechao Wang | Frank De Wolf | Clifford Lane | Joep Lange | Antonella D‘Arminio Monforte | L. Ruíz
[1] S. Agatonovic-Kustrin,et al. Basic concepts of artificial neural network (ANN) modeling and its application in pharmaceutical research. , 2000, Journal of pharmaceutical and biomedical analysis.
[2] Victoria A Johnson,et al. Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[3] B. Larder,et al. Enhanced prediction of lopinavir resistance from genotype by use of artificial neural networks. , 2003, The Journal of infectious diseases.
[4] P. Narciso,et al. Variable prediction of antiretroviral treatment outcome by different systems for interpreting genotypic human immunodeficiency virus type 1 drug resistance. , 2003, Journal of Infectious Diseases.
[5] Thomas Lengauer,et al. Geno2pheno: estimating phenotypic drug resistance from HIV-1 genotypes , 2003, Nucleic Acids Res..
[6] V. Soriano,et al. Correlation between rules-based interpretation and virtual phenotype interpretation of HIV-1 genotypes for predicting drug resistance in HIV-infected individuals. , 2004, Journal of virological methods.
[7] W Preiser,et al. Variety of interpretation systems for human immunodeficiency virus type 1 genotyping: confirmatory information or additional confusion? , 2003, Current drug targets. Infectious disorders.
[8] F. Pociot,et al. Novel analytical methods applied to type 1 diabetes genome-scan data. , 2004, American journal of human genetics.
[9] A. Aceti,et al. Genotypic resistance tests in the management of the HIV-infected patient at virological failure. , 2003, Scandinavian journal of infectious diseases. Supplementum.
[10] R. Samudrala,et al. Simple Linear Model Provides Highly Accurate Genotypic Predictions of HIV-1 Drug Resistance , 2003, Antiviral therapy.
[11] Richard A. Rode,et al. Identification of Genotypic Changes in Human Immunodeficiency Virus Protease That Correlate with Reduced Susceptibility to the Protease Inhibitor Lopinavir among Viral Isolates from Protease Inhibitor-Experienced Patients , 2001, Journal of Virology.
[12] Ben S. Gerber,et al. Use of genetic algorithms for neural networks to predict community-acquired pneumonia , 2004, Artif. Intell. Medicine.
[13] JD Lundgren,et al. Updated European Recommendations for the Clinical Use of HIV Drug Resistance Testing , 2004, Antiviral therapy.
[14] B. Clotet,et al. Clinical management of treatment-experienced, HIV-infected patients with the fusion inhibitor enfuvirtide: consensus recommendations , 2004, AIDS.
[15] D. Katzenstein,et al. Weighted phenotypic susceptibility scores are predictive of the HIV-1 RNA response in protease inhibitor-experienced HIV-1-infected subjects. , 2004, The Journal of infectious diseases.
[16] Thomas Lengauer,et al. Data and text mining Computational methods for the design of effective therapies against drug resistant HIV strains , 2005 .
[17] C. Tinelli,et al. Comparison between rules-based human immunodeficiency virus type 1 genotype interpretations and real or virtual phenotype: concordance analysis and correlation with clinical outcome in heavily treated patients. , 2003, The Journal of infectious diseases.
[18] Victor DeGruttola,et al. Clinically Validated Genotype Analysis: Guiding Principles and Statistical Concerns , 2004, Antiviral therapy.
[19] S. Staszewski,et al. Comparison of Nine Resistance Interpretation Systems for HIV-1 Genotyping , 2002, Antiviral therapy.
[20] Thomas Lengauer,et al. Diversity and complexity of HIV-1 drug resistance: A bioinformatics approach to predicting phenotype from genotype , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[21] Elie Bienenstock,et al. Neural Networks and the Bias/Variance Dilemma , 1992, Neural Computation.
[22] Chen-Khong Tham,et al. Predicting Risk of Coronary Artery Disease from Dna Microarray-based Genotyping Using Neural Networks and Other Statistical Analysis Tool , 2003, J. Bioinform. Comput. Biol..
[23] L. Sandvik,et al. An algorithm‐based genotypic resistance score is associated with clinical outcome in HIV‐1‐infected adults on antiretroviral therapy , 2004, HIV medicine.
[24] A. Kelleher,et al. A Randomised Trial Comparing Genotypic and Virtual Phenotypic Interpretation of HIV Drug Resistance: The CREST Study , 2006, PLoS clinical trials.
[25] S. Deeks,et al. Treatment of antiretroviral-drug-resistant HIV-1 infection , 2003, The Lancet.